Big breakthrough! Serum Institute of India develops first indigenous vaccine against pneumonia; launch next week

The vaccine will be much more affordable than existing ones manufactured by two foreign companies. India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.

https://ift.tt/eA8V8J
https://ift.tt/3heCc8Q